Literature DB >> 3302047

Hybridoma technology: new developments of practical interest.

S R Samoilovich, C B Dugan, A J Macario.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3302047      PMCID： PMC7130749          DOI： 10.1016/0022-1759(87)90147-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN： 0022-1759            Impact factor:   2.303


× No keyword cloud information.
  102 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Improved fusion methods. IV. Technical aspects.

Authors:  R J Westerwoudt
Journal:  J Immunol Methods       Date:  1985-03-18       Impact factor: 2.303

3.  Monoclonal antibody production by receptor-mediated electrically induced cell fusion.

Authors:  M M Lo; T Y Tsong; M K Conrad; S M Strittmatter; L D Hester; S H Snyder
Journal:  Nature       Date:  1984 Aug 30-Sep 5       Impact factor: 49.962

4.  Cloned mycoplasma ribosomal RNA genes for the detection of mycoplasma contamination in tissue cultures.

Authors:  U B Göbel; E J Stanbridge
Journal:  Science       Date:  1984-12-07       Impact factor: 47.728

5.  Human hybridoma cells produced by electro-fusion.

Authors:  R Bischoff; R M Eisert; I Schedel; J Vienken; U Zimmerman
Journal:  FEBS Lett       Date:  1982-10-04       Impact factor: 4.124

6.  Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient.

Authors:  K Nilsson; H Bennich; S G Johansson; J Pontén
Journal:  Clin Exp Immunol       Date:  1970-10       Impact factor: 4.330

7.  Human and chimpanzee monoclonal antibodies.

Authors:  F C Van Meel; P G Steenbakkers; J C Oomen
Journal:  J Immunol Methods       Date:  1985-06-25       Impact factor: 2.303

8.  Serum-free medium for hybridoma and parental myeloma cell cultivation: a novel composition of growth-supporting substances.

Authors:  J Kovár; F Franĕk
Journal:  Immunol Lett       Date:  1984       Impact factor: 3.685

Review 9.  The use of Epstein-Barr virus transformation for the production of human monoclonal antibodies.

Authors:  A J Roome; C L Reading
Journal:  Exp Biol       Date:  1984

10.  Rat monoclonal antibodies. III. A simple method for facilitation of hybridoma cell growth in vivo.

Authors:  F Hirsch; B Vendeville; L De Clercq; H Bazin; P Druet
Journal:  J Immunol Methods       Date:  1985-04-08       Impact factor: 2.303
View more
  6 in total

1.  Tumour-associated antigens of mammary carcinomas recognized by human monoclonal antibody 1G12.

Authors:  X L Chen; S Kaul; G Bastert
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

2.  Serum-free growth medium for the cultivation of a wide spectrum of mammalian cells in stirred bioreactors.

Authors:  V Jäger; J Lehmann; P Friedl
Journal:  Cytotechnology       Date:  1988-11       Impact factor: 2.058

3.  Enhancement of the attachment on microcarriers and tPA production by fibroblast cells in a serum-free medium by the addition of the extracts of Centella asiatica.

Authors:  Y N Kim; Y S Park; H K Kim; B C Jeon; S E Youn; H Y Lee
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

4.  Ganglioside alterations in YAC-1 cells cultivated in serum-supplemented and serum-free growth medium.

Authors:  J Müthing; A Pörtner; V Jäger
Journal:  Glycoconj J       Date:  1992-10       Impact factor: 2.916

5.  Molecular organization of recombinant human-Arabidopsis chromosomes in hybrid cell lines.

Authors:  Yikun Liu; Yeng Mun Liaw; Chee How Teo; Petr Cápal; Naoki Wada; Kiichi Fukui; Jaroslav Doležel; Nobuko Ohmido
Journal:  Sci Rep       Date:  2021-03-30       Impact factor: 4.379

Review 6.  Hybridoma technology; advancements, clinical significance, and future aspects.

Authors:  Sanchita Mitra; Pushpa Chaudhary Tomar
Journal:  J Genet Eng Biotechnol       Date:  2021-10-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.